Content by Analytik Jena AG
With the multi N/C 2100S pharma and 3100 pharma, two new device models are being introduced
In the future, customers will be able to configure every system in the ICP-MS series to suit their individual requirements
Thanks to a large range of accessories, the novAA® 800 can be optimized to meet individual requirements such as sample throughput, precision, and ease of use
The focus of the two partners’ future research efforts will be on the development of new devices and applications for element determination
For the clinical industry, the transition from atomic absorption spectroscopy (AAS) to inductively coupled plasma-mass spectrometry (ICP-MS) has been gradual over the past two decades
SmartExtraction is a global innovation in nucleic acid extraction
One of the most important business acquisitions in the history of Analytik Jena AG has been closed.